BEATS 2: Music Therapy in Sickle Cell
BEATS 2: The Effects of Music Therapy on Young Adults With Sickle Cell Disease
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to investigate the effects of the BEATS music therapy program on the self-efficacy, trust, knowledge, and adherence of young adult patients with SCD. Primary Hypotheses: Compared to baseline, young adult patients with SCD who receive the music therapy interventions will report: Higher sickle cell self-efficacy as measured by the Sickle Cell Self Efficacy Scale (SCSES), Higher trust in health care providers as measured by the Wake Forest Trust in the Medical Profession Scale, and Higher SCD knowledge as measured by the Seidman Sickle Cell Knowledge Quiz. Secondary Hypotheses Compared to the one year prior to the study period, young adults with SCD who receive the music therapy interventions will have a higher rate of adherence to clinic appointments during the one-year study period. Additional Questions Do music therapy interventions influence the rate of hospital utilization as measured by ED visits, Acute Care Clinic (ACC) visits, and admissions during the study period compared to the previous year? Do music therapy interventions influence adherence to hydroxyurea therapy for patients receiving hydroxyurea as measured by change in mean corpuscular volume (MCV) during the study period? Do music therapy interventions influence adherence to iron chelation therapy for patients receiving iron chelation therapy as measured by ferritin count during the study period? Does the schedule of music therapy interventions in this study improve outcomes more significantly than the schedule of music therapy interventions from \[IRB# 03-15-30\]?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 26, 2017
CompletedFirst Submitted
Initial submission to the registry
July 25, 2017
CompletedFirst Posted
Study publicly available on registry
July 28, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2018
CompletedOctober 22, 2018
October 1, 2018
1.3 years
July 25, 2017
October 19, 2018
Conditions
Outcome Measures
Primary Outcomes (3)
Change from baseline in scores on the Sickle Cell Self-Efficacy Scale (SCSES)
Self-efficacy is the conviction that one can successfully execute the behavior required to produce the outcome. (Bandura, 1997, p. 193). The SCSES is a nine-item Likert scale originally developed for adults with sickle cell disease (Edwards, Telfair, Cecil, \& Lenoci, 2000) and revised in a follow up study by Clay and Telfair (2007) for adolescents using a sample of 131 individuals age 11-19.
Baseline, immediately after session 4, 4 weeks after session 4, immediately after session 8, 4 weeks after session 8.
Change from baseline in scores on the Wake Forest Trust in the Medical Profession Scale
Patient trust is the optimistic acceptance of a vulnerable situation in which the patient believes the health-care provider will take care of the patient's interests (Dugan, Trachtenberg, \& Hall, 2005).The Wake Forest Trust in the Medical Profession Scale is a five-item scale in which respondents express their level of agreement with the following statements: 1) Sometimes doctors care more about what is convenient for them than about their patients' medical needs (reverse coded); 2) Doctors are extremely thorough and careful; 3) You completely trust doctors' decisions about which medical treatments are best; 4) A doctor would never mislead you about anything; 5) All in all, you trust your doctor completely. Responses are summed and scores are on a 5-25 scale, with higher values indicating greater trust.
Baseline, immediately after session 4, 4 weeks after session 4, immediately after session 8, 4 weeks after session 8.
Change from baseline in scores on the Seidman Sickle Cell Knowledge Quiz
Sickle Cell Disease knowledge will be measured using the Seidman Sickle Cell Knowledge Quiz developed specifically for this study. The Seidman Sickle Cell Knowledge Quiz is adapted from questions from the Sickle Cell Disease Knowledge Test (Kaslow et al., 2000) and How Much Do I Know About Sickle Cell Disease (Baskin, Collins, Kaslow, \& Hsu, 2002).
Baseline, immediately after session 4, 4 weeks after session 4, immediately after session 8, 4 weeks after session 8.
Secondary Outcomes (1)
Change from baseline in rate of adherence to clinic appointments during the one-year study period.
Baseline, 12 months
Study Arms (1)
Music Therapy Group
EXPERIMENTALMusic therapy is the clinical and evidence-based use of music interventions to accomplish individualized goals within a therapeutic relationship by a credentialed professional who has completed an approved music therapy program. Music therapy is an established health profession in which music is used within a therapeutic relationship to address physical, emotional, cognitive, and social needs of individuals (American Music Therapy Association \[AMTA\], 2013, para 1 and 2).
Interventions
During the educational music therapy intervention, member(s) of the Adult Sickle Cell Disease team will share with the patients the medical information pertinent to the appointment via a prerecorded video. The Music Therapist will then engage the patients in a music therapy intervention designed to teach and reinforce the skills and knowledge presented. These music therapy interventions may include but are not limited to original songs/rap/instrumental playing, vocal and/or instrumental improvisation, patient-contributed lyrics, mnemonics, and stress and pain reducing strategies. The music therapy interventions will be tailored to best convey the educational message.
Eligibility Criteria
You may qualify if:
- Subject is between 18 and 35 years of age
- Subject is diagnosed with sickle cell disease
- Subject is able to speak and understand English
- Subject has a working email address.
- Subject has access to a mobile device with email capabilities.
You may not qualify if:
- Subject has significant hearing impairment that has not been corrected
- Subject has significant visual impairment that has not been corrected
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospitals Cleveland Medical Centerlead
- Kulas Foundationcollaborator
Study Sites (1)
University Hospitals Seidman Cancer Center
Cleveland, Ohio, 44106, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel N Rodgers-Melnick, MT-BC
University Hospitals
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Music Therapist-Board Certified
Study Record Dates
First Submitted
July 25, 2017
First Posted
July 28, 2017
Study Start
June 26, 2017
Primary Completion
September 30, 2018
Study Completion
September 30, 2018
Last Updated
October 22, 2018
Record last verified: 2018-10